Not yet recruiting

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

By April 24, 2017 No Comments

Condition

Mesothelioma

Estimated Enrollment: 17

Age Group: 21 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: OS-MES-P2-01

Study First Received: June 20, 2012

Last Updated: March 28, 2016

Estimated Primary Completion Date: August 2018

 

Primary Outcome Measures:

Adverse events and serious adverse events occurence|overall survival time

Sponsors and Collaborators:

Oshadi Drug Administration

Website Link: https://ClinicalTrials.gov/show/NCT01627795

Leave a Reply

Call Now